Iksuda Therapeutics
Pre-clinicalIksuda is a biotechnology company with a world-class ADC R&D team focused on the development of the best ADC for any given target and tumor indication.
Founded
2017
Focus
AntibodiesBiologics
About
Iksuda is a biotechnology company with a world-class ADC R&D team focused on the development of the best ADC for any given target and tumor indication.
Funding History
2Total raised: $89M
Series B$42MTCG CrossoverMar 15, 2023
Series A$47MTCG CrossoverOct 15, 2021
Company Info
TypePrivate
Founded2017
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile